Scott and White Clinic

Temple, TX, United States

Scott and White Clinic

Temple, TX, United States
Time filter
Source Type

Desai R.R.,University of Louisville | Malkani A.L.,University of Louisville | Hitt K.D.,Scott and White Clinic | Jaffe F.F.,New York University | And 2 more authors.
Journal of Arthroplasty | Year: 2012

The purpose of this study was to compare results of patients with Paprosky type I and II femoral defects vs type IIIA, IIIB, and IV defects in patients undergoing revision hip arthroplasty. There were 64 patients in the group with type I and II defects with an average age of 68 years. There were 52 patients with Paprosky type IIIA, IIIB, and IV defects with an average age of 67 years. There were 8 intraoperative fractures in the type III and IV group, whereas there were 9 in the type I and II group. There were no differences between the 2 groups with respect to subsidence, loosening, dislocation, infection, and medical complications. Survivorship for the whole group was 96.9% at 5 years. Modular femoral implants provide several intraoperative options to restore leg length, offset, and stability despite femoral defects. We did not realize a higher failure rate in patients with type III or IV defects. © 2012 Elsevier Inc..

Zivkovic A.M.,University of California at Davis | Yang J.,University of California at Davis | Georgi K.,University of California at Davis | Hegedus C.,University of California at Davis | And 7 more authors.
Metabolomics | Year: 2012

Immunoglobulin A nephropathy (IgAN) is a leading cause of chronic kidney disease, frequently associated with hypertension and renal inflammation. ω-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in fish oil (FO) improve kidney function in animal models, but have inconsistent metabolic effects in humans. Oxylipin profiles in serum from IgAN patients supplemented with either FO or corn oil (CO) placebo were analyzed by liquid chromatography coupled to tandem mass spectrometry. EPA cyclooxygenase and lipoxygenase metabolites, and EPA and DHA epoxides and diols were increased in response to FO supplementation, as were total epoxides and epoxide/diol ratios. Several of these metabolites were drivers of separation as assessed by multivariate analysis of FO patients pre- versus post-supplementation, including 17,18-dihydroxyeicosatrienoic acid, prostaglandin D 3, prostagalandin E 3, Resolvin E1, 12-hydroxyeicosapentaenoic acid, and 10(11)-epoxydocosapentaenoic acid. In patients whose proteinuria improved, plasma total oxylipins as well as several hydroxyoctadecadienoic acids, hydroxyeicosatetraenoic acids, and leukotriene B 4 metabolites were among the metabolites that were significantly lower than in patients whose proteinuria either did not improve or worsened. These data support the involvement of oxylipins in the inflammatory component of IgAN as well as the potential use of oxylipin profiles as biomarkers and for assessing responsiveness to ω-3 fatty acid supplementation in IgAN patients. © 2012 Springer Science+Business Media, LLC.

Nording M.L.,Umeå University | Nording M.L.,University of California at Davis | Yang J.,University of California at Davis | Georgi K.,University of California at Davis | And 8 more authors.
PLoS ONE | Year: 2013

Introduction:Conflicting findings in both interventional and observational studies have resulted in a lack of consensus on the benefits of ω3 fatty acids in reducing disease risk. This may be due to individual variability in response. We used a multi-platform lipidomic approach to investigate both the consistent and inconsistent responses of individuals comprehensively to a defined ω3 intervention.Methods:The lipidomic profile including fatty acids, lipid classes, lipoprotein distribution, and oxylipins was examined multi- and uni-variately in 12 healthy subjects pre vs. post six weeks of ω3 fatty acids (1.9 g/d eicosapentaenoic acid [EPA] and 1.5 g/d docosahexaenoic acid [DHA]).Results:Total lipidomic and oxylipin profiles were significantly different pre vs. post treatment across all subjects (p=0.00007 and p=0.00002 respectively). There was a strong correlation between oxylipin profiles and EPA and DHA incorporated into different lipid classes (r2=0.93). However, strikingly divergent responses among individuals were also observed. Both ω3 and ω6 fatty acid metabolites displayed a large degree of variation among the subjects. For example, in half of the subjects, two arachidonic acid cyclooxygenase products, prostaglandin E2 (PGE2) and thromboxane B2 (TXB2), and a lipoxygenase product, 12-hydroxyeicosatetraenoic acid (12-HETE) significantly decreased post intervention, whereas in the other half they either did not change or increased. The EPA lipoxygenase metabolite 12-hydroxyeicosapentaenoic acid (12-HEPE) varied among subjects from an 82% decrease to a 5,000% increase.Conclusions:Our results show that certain defined responses to ω3 fatty acid intervention were consistent across all subjects. However, there was also a high degree of inter-individual variability in certain aspects of lipid metabolism. This lipidomic based phenotyping approach demonstrated that individual responsiveness to ω3 fatty acids is highly variable and measurable, and could be used as a means to assess the effectiveness of ω3 interventions in modifying disease risk and determining metabolic phenotype. © 2013 Nording et al.

Swanson G.P.,University of Texas Health Science Center at San Antonio | Du F.,University of Texas Health Science Center at San Antonio | Michalek J.E.,University of Texas Health Science Center at San Antonio | Hermans M.,Scott and White Clinic
International Journal of Radiation Oncology Biology Physics | Year: 2011

Purpose: The results of salvage radiation therapy for rising prostate-specific antigen (PSA) levels after radical prostatectomy appear favorable, but the ultimate outcome is uncertain, given the relatively short follow-up in most studies. We report on a group of patients at a median follow-up of 13.9 years after salvage radiation therapy. Methods and Materials: From 1990 to 1995, 92 patients were referred postoperatively for radiation for a rising PSA level. PSA level at the time of referral ranged from 0.1 to 30.5 ng/ml (median, 1.5 ng/ml). The median time from surgery to radiation was 2.1 years (range, 0.3-7.4 years). Radiation was directed to the prostatic fossa only with a median dose of 6,500 cGy (range, 6,000-7,000 cGy). Results: Eighty-five patients experienced a PSA drop after radiation, as predicted by Gleason score and PSA level at the start of radiation. Five- and 10-year biochemical failure free survival (BFFS) was 35% and 26%, respectively, and overall survival was 86% and 67%, respectively. Median survival was 12.0 years, and median BFF was 2.3 years. The presurgery PSA level was not predictive, but the PSA level at the start of radiation predicted a response. Patients with Gleason 8 to 9 cancers had a significantly higher progression rate than those with lower Gleason scores. There were no significant differences in outcomes based on pathology findings (none vs. positive margins vs. positive seminal vesicles). Overall, 22 (24%) patients died directly from prostate cancer, resulting in a 10-year cancer-specific survival rate of 82%. Multivariate analysis risk factors for dying of cancer were Gleason's score (8 to 9) and PSA at the start of radiation therapy (>1.0 ng/ml). Conclusions: Patients have a good response to salvage radiation therapy. A small but durable subgroup appears to have permanent control. In those for whom therapy fails, radiation delays the need for other salvage therapy, indicating at least a transient benefit to most patients. © 2011 Elsevier Inc.

Perez E.,Texas State University | Ntaimo L.,Texas A&M University | Malave C.O.,Texas A&M University | Bailey C.,Scott and White Clinic | McCormack P.,Scott and White Clinic
Health Care Management Science | Year: 2013

The increased demand for medical diagnosis procedures has been recognized as one of the contributors to the rise of health care costs in the U.S. in the last few years. Nuclear medicine is a subspecialty of radiology that uses advanced technology and radiopharmaceuticals for the diagnosis and treatment of medical conditions. Procedures in nuclear medicine require the use of radiopharmaceuticals, are multi-step, and have to be performed under strict time window constraints. These characteristics make the scheduling of patients and resources in nuclear medicine challenging. In this work, we derive a stochastic online scheduling algorithm for patient and resource scheduling in nuclear medicine departments which take into account the time constraints imposed by the decay of the radiopharmaceuticals and the stochastic nature of the system when scheduling patients. We report on a computational study of the new methodology applied to a real clinic. We use both patient and clinic performance measures in our study. The results show that the new method schedules about 600 more patients per year on average than a scheduling policy that was used in practice by improving the way limited resources are managed at the clinic. The new methodology finds the best start time and resources to be used for each appointment. Furthermore, the new method decreases patient waiting time for an appointment by about two days on average. © 2013 Springer Science+Business Media New York.

Petersen J.R.,University of Texas Medical Branch | Omoruyi F.O.,Texas A&M University-Corpus Christi | Mohammad A.A.,Scott and White Clinic | Shea T.J.,University of Texas Medical Branch | And 2 more authors.
Clinica Chimica Acta | Year: 2010

Background: Glycosylated hemoglobin evaluation is very important for assessing the control of diabetes. Since the use of point-of-care (POC) devices for monitoring HbA1c is increasing, it is important to determine how these devices compare in relation to instrumentation used in the central laboratory (CL). Methods: Eighty-eight randomly selected samples previously analyzed using the Bio-Rad Variant™ II Hemoglobin Testing System were run on three POC Analyzers (Siemens DCA Vantage™ Analyzer, Axis-Shield Afinion™ AS100 Analyzer, and Bio-Rad In2it™ Analyzer). Results: All POC instruments showed good correlation to the CL method (R2>0.95 for all methods). HbA1c levels obtained using Variant II (mean=7.9; 95% CI=7.5-8.3%) and In2it (mean=7.9; 95% C.I.=7.5-8.2%) instruments were found to have no statistical mean difference (p=0.21), while the values obtained using DCA Vantage (mean=7.2% C.I.=6.9-7.5%) and Afinion (mean=7.3% C.I.=7.0-7.6%) instruments were different (p<0.001) from those of the CL method. The Afinion and DCA Vantage instruments increasingly underestimated the HbA1c compared to the CL as the HbA1c values increased. These differences were even more striking when the estimated average glucose is calculated. Conclusions: Despite significant variation of results among the POC instruments evaluated relative to the CL method and pending resolution of HbA1c standardization issues, we conclude that all of the POC instruments can be used for HbA1c determination if clinicians are given instrument specific reference ranges. © 2010 Elsevier B.V.

Yagi M.,National Hospital Organization Murayama Medical Center | Rahm M.,Scott and White Clinic | Gaines R.,Columbia Spine Center and Orthopaedic Group | Maziad A.,Hospital for Special Surgery | And 4 more authors.
Spine | Year: 2014

STUDY DESIGN.: Retrospective case series of surgically treated patients with adult spine deformity (ASD). OBJECTIVE.: To report the incidence of proximal junctional failure (PJF), characterize PJF and evaluate the outcome of revision surgery for PJF. A modified classification is also proposed. SUMMARY OF BACKGROUND DATA.: Although recent reports have shown the catastrophic results of PJF, few reports have shown the incidence, characteristics, and clinical outcomes of PJF in ASD. METHODS.: This retrospective analysis reviewed data entered prospectively into a multicenter database. Surgically treated patients with ASD with a minimum 2-year follow-up were included. PJF was defined as any type of symptomatic proximal junctional kyphosis (PJK) requiring surgery. On the basis of our previous classification, the following modified PJK classification was established: grade A, proximal junctional increase of 10° to 19°; grade B, 20° to 29°; and grade C, 30° or more. Three types of PJK were also defined: ligamentous failure (type 1), bone failure (type 2), and implant/bone interface failure (type 3). An additional criterion was added for the presence or absence of spondylolisthesis above the upper instrumentation vertebra (UIV). RESULTS.: PJF developed in 23 of the 1668 patients with ASD. The incidence of PJF was 1.4%. The mean age was 62.3 ± 7.9 years, and the mean follow-up was 4.0 ± 2.3 years. Seventeen patients had undergone prior surgical procedures. Six patients had UIV above T8, and 17 had UIV below T9. Six patients had associated spondylolisthesis above the UIV (PJF-S), whereas 17 patients did not (PJF-N). The radiographical data show a significant difference in the preoperative sagittal vertical axis between the PJF-S and PJF-N groups, whereas no significant difference was observed in the preoperative sagittal parameters (5.2 ± 3.9 cm vs. 11.4 ± 6.0 cm, P = 0.04). The most common type of PJF was type 2N. The PJF symptoms consisted of intolerable pain (n = 17), neurological deficits (n = 6), and progressive trunk deformity (n = 1). Eleven patients had additional PJK/PJF and 9 required additional revision surgical procedures. CONCLUSION.: The incidence of PJF among surgically treated patients with ASD was 1.4%. The most common type of PJF was 2N. Preoperative large sagittal vertical axis change and large amount of correction was a causative factor for spondylolisthesis above the UIV. After the revision surgery, further PJF was a commonly occurred event. Copyright © 2014 Lippincott Williams & Wilkins.

Holmes Jr. D.R.,Mayo Medical School | Kereiakes D.J.,Christ Hospital Heart | Garg S.,Erasmus Medical Center | Serruys P.W.,Erasmus Medical Center | And 5 more authors.
Journal of the American College of Cardiology | Year: 2010

Intense investigation continues on the pathobiology of stent thrombosis (ST) because of its morbidity and mortality. Because little advance has been made in outcomes following ST, ongoing research is focused on further understanding predictive factors as well as ST frequency and timing in various patient subsets, depending upon whether a drug-eluting stent or bare-metal stent has been implanted. Although the preventive role of antiplatelet therapies remains unchallenged, new data on genomics and variability in response to antiplatelet therapy, as well as the effects of novel therapeutic agents and duration of therapy, have become available. The goal remains identification of patients at particularly increased risk of ST so that optimal prevention strategies can be developed and employed. © 2010 American College of Cardiology Foundation.

Perez E.,Texas A&M University | Ntaimo L.,Texas A&M University | Bailey C.,Scott and White Clinic | McCormack P.,Scott and White Clinic
Simulation | Year: 2010

Increased demand for specialized healthcare services has been identified as one of the causes of increased healthcare costs in the US. Nuclear medicine, a sub-specialty of radiology, uses relatively new technology to diagnose and treat patients. Procedures (tests) in nuclear medicine require the use of radiopharmaceuticals with a limited half-life and involve several steps that are constrained by strict time windows and require multiple resources for completion. Consequently, managing patient service in nuclear medicine is a very challenging problem that has received very little research attention. In this paper, we present a discrete event system specification (DEVS) simulation model for nuclear medicine patient service management that considers both patient and management perspectives. DEVS is a formal modeling and simulation framework based on dynamical systems theory and provides well-defined concepts for coupling components, hierarchical and modular model construction, and an object-oriented substrate supporting repository reuse. We report on simulation results based on historical data using both patient and management performance measures. The results provide useful insights regarding the management of patient service in nuclear medicine. While this work focuses on nuclear medicine, results will find generality in other healthcare settings. © 2010 The Society for Modeling and Simulation International.

Farber A.,Boston Medical Center | Long B.M.,Cedars Sinai Medical Center | Bohannon T.,Scott and White Clinic | Siegal C.L.,New Hill
Journal of Vascular Surgery | Year: 2010

During the past decade, there has been a sharp increase in the number of vascular procedures performed in the United States. Due to the increase in the size of the aging population, this trend is predicted to continue. Despite this, general public knowledge about vascular surgery appears low. This gap may significantly affect the success of vascular surgery as a specialty. To objectively define knowledge about vascular surgery, we administered a questionnaire to both a sample of the general population and medical students. The Vascular Surgery Knowledge Questionnaire (VSQ), a 58-item multiple choice survey, was designed to assess knowledge about the field of vascular surgery, including types of procedures commonly performed, presenting illnesses, training, and financial compensation. VSQ was tested for reliability and validity. It was administered to a sample of the general population (GP) and first year medical students (MS) via a random digit dial telephone survey and a paper-based survey, respectively. VSQ Score was derived by calculating the percent of questions from the 38-item, non-demographic part of the questionnaire answered correctly and expressed in numerical form. The maximum score possible was 100. Statistical analysis was used to assess differences in VSQ scores. Two hundred GP and 160 MS subjects completed the questionnaire. The mean VSQ score for GP and MS groups was 54 and 67 (P < .01), respectively. Forty-one percent of the GP group received a score of less than 50. Only 50% of the GP and 51% of MS cohorts agreed with the statement that vascular surgeons perform procedures on all blood vessels with the exception of the heart and brain. Just 24% of the GP group agreed with the statement that vascular surgeons treat patients with wounds that do not heal. Finally, only half of the GP group agreed that vascular surgeons treat patients with abdominal aortic aneurysms. The GP cohort significantly underestimated the average length of postgraduate training (five years) to become a vascular surgeon. Level of education, income, and residence in the Western states significantly correlated with higher scores. General population subjects who admitted to knowing a vascular surgeon received similar scores to those who did not (58 vs. 53, P >.05). These findings support our hypothesis that there is a significant knowledge deficit among both the general population and medical students about the field of vascular surgery. This has protean implications for the future of our specialty and public health in the United States. © 2010 Society for Vascular Surgery.

Loading Scott and White Clinic collaborators
Loading Scott and White Clinic collaborators